20 unknown. 20 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 20 | Unknown 20 |
Follow Hydroxychloroquine: new trials by email Literature Review of Hydroxychloroquine trials Research Report on Hydroxychloroquine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multi-omics Studies on the Efficacy of Telitacicept in Chinese SLE Patients Telitacicept, Hydroxychloroquine, Prednisone - Systemic Lupus Erythematosus | Phase 4 | Unknown | Fen Li | 30 | 2022-12-31 | 2024-01-17 |
| A Study of Hydroxychloroquine Sulfate in the Treatment of Recurrent Spontaneous Abortion With Antiphospholipid Syndrome Hydroxychloroquine Sulfate Tablets - Antiphospholipid Syndrome, Recurrent Miscarriage | Phase 4 | Unknown | Shanghai First Maternity and Infant Hospital | 384 | 2020-12-01 | 2020-11-10 |
| Safety and Efficacy of Doxycycline and Rivaroxaban in COVID-19 Doxycycline Tablets, Rivaroxaban 15Mg Tab, Hydroxychloroquine and Azithromycin - COVID-19 | Phase 4 | Unknown | Yaounde Central Hospital | 200 | 2020-10-05 | 2021-01-20 |
| Comparative Therapeutic Efficacy and Safety of Different Antiviral and Anti Inflammatory Drugs in COVID-19 Patients. Remdesivir, Hydroxychloroquine, Tocilizumab - Covid19, Pneumonia | Phase 4 | Unknown | October 6 University | 150 | 2020-10-01 | 2021-03-17 |
| Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease Hydroxychloroquine, Placebo - COVID-19 | Phase 4 | Unknown | WellStar Health System | 700 | 2020-05-07 | 2020-06-16 |
| Favipiravir in Hospitalized COVID-19 Patients Favipiravir, Hydroxychloroquine - COVID-19 | Phase 4 | Unknown | Shahid Beheshti University of Medical Sciences | 40 | 2020-04-20 | 2020-04-28 |
| Azithromycin in Hospitalized COVID-19 Patients Hydroxychloroquine, Azithromycin - COVID-19 | Phase 4 | Unknown | Shahid Beheshti University of Medical Sciences | 40 | 2020-04-20 | 2020-04-24 |
| Interferon Beta 1a in Hospitalized COVID-19 Patients Interferon Beta-1A, Lopinavir / Ritonavir, Single Dose of Hydroxychloroquine - COVID-19 | Phase 4 | Unknown | Shahid Beheshti University of Medical Sciences | 40 | 2020-04-15 | 2020-04-20 |
| Umifenovir in Hospitalized COVID-19 Patients Umifenovir, Interferon-β 1a, Lopinavir / Ritonavir - COVID-19 | Phase 4 | Unknown | Shahid Beheshti University of Medical Sciences | 40 | 2020-04-15 | 2020-04-20 |
| Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia Bromhexine Oral Tablet and/or hydroxychloroquine tablet - Covid-19 | Phase 4 | Unknown | General and Teaching Hospital Celje | 90 | 2020-04-10 | 2020-04-21 |
| Norwegian Coronavirus Disease 2019 Study Hydroxychloroquine Sulfate - Corona Virus Infection | Phase 4 | Unknown | University Hospital, Akershus | 53 | 2020-03-25 | 2020-06-05 |
| Treat-to-target Strategy in Ankylosing Spondylitis Using Etanercept and Conventional Synthetic DMARDs Methotrexate, Sulfasalazine, Hydroxychloroquine - Ankylosing Spondylitis, Spondyloarthritis | Phase 4 | Unknown | Nanfang Hospital, Southern Medical University | 100 | 2019-10-07 | 2019-09-26 |
| Effect of Bitter in Overweight Female Volunteers Hydroxychloroquine sulphate, Placebo - Obesity | Phase 4 | Unknown | Universitaire Ziekenhuizen KU Leuven | 40 | 2019-10-01 | 2019-07-02 |
| Effect of Hydroxychloroquine Sulphate in Healthy Lean Females Hydroxychloroquine Sulphate, Placebo - Obesity | Phase 4 | Unknown | Universitaire Ziekenhuizen KU Leuven | 10 | 2019-08-01 | 2019-07-02 |
| Anti-Inflammatory Drug and Endothelial Function Hydroxychloroquine, Placebo oral tablet - Cardiovascular Diseases, Endothelial Dysfunction | Phase 4 | Unknown | Instituto de Cardiologia do Rio Grande do Sul | 50 | 2019-07-01 | 2019-11-13 |
| Targeted Treatment Early With Etanercept + Methotrexate vs.T2T Care for DMARD-naïve Early RA Patients Based on naïve T-cell Stratification Benepali, Sulfasalazine, Methotrexate - Rheumatoid Arthritis | Phase 4 | Unknown | University of Leeds | 106 | 2019-03-01 | 2019-01-23 |
| Effect of Hydroxychloroquine on Atrial Fibrillation Recurrence Hydroxychloroquine Sulfate 200 Mg Tablet - Atrial Fibrillation | Phase 4 | Unknown | First Affiliated Hospital of Harbin Medical University | 240 | 2018-08-01 | 2018-07-19 |
| Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA Nephropathy Hydroxychloroquine Sulfate, Valsartan - Primary IgA Nephropathy | Phase 4 | Unknown | Peking Union Medical College Hospital | 98 | 2016-06-01 | 2017-09-20 |
| Dose Reduction for Early Rheumatoid Arthritis Patients With Low Disease Activity Sulphasalazine + Hydroxychloroquine OR Prednisolone, Cimzia, Orencia - Rheumatoid Arthritis | Phase 4 | Unknown | Karolinska Institutet | 25 | 2015-02-03 | 2022-07-08 |
| TNF-blocking Therapy in Combination With Disease-modifying Antirheumatic Drugs in Early Rheumatoid Arthritis Trexan+Salazopyrin+Oxiklorin+prednisolone + infliximab, Trexan+Salazopyrin+Oxiklorin+prednisolone + placebo - Rheumatoid Arthritis | Phase 4 | Unknown | University of Helsinki | 100 | 2003-03-01 | 2015-04-01 |
COVID-19 (8) · Arthritis, Rheumatoid (3) · Obesity (2) · Abortion, Habitual (1) · Antiphospholipid Syndrome (1) · Atherosclerosis (1) · Atrial Fibrillation (1) · Autoimmune Diseases (1) · Cardiovascular Diseases (1) · Coronary Artery Disease (1) · Coronavirus Infections (1) · Glomerulonephritis (1) · Glomerulonephritis, IGA (1) · Immune System Diseases (1) · Kidney Diseases (1)
Shahid Beheshti University of Medical Sciences (4) · Universitaire Ziekenhuizen KU Leuven (2) · Fen Li (1) · First Affiliated Hospital of Harbin Medical University (1) · General and Teaching Hospital Celje (1) · Instituto de Cardiologia do Rio Grande do Sul (1) · Karolinska Institutet (1) · Nanfang Hospital, Southern Medical University (1) · October 6 University (1) · Peking Union Medical College Hospital (1) · Shanghai First Maternity and Infant Hospital (1) · University Hospital, Akershus (1) · University of Helsinki (1) · University of Leeds (1) · WellStar Health System (1)
China (5) · Iran (4) · Brazil (1) · Cameroon (1) · Egypt (1) · Finland (1) · Norway (1) · Slovenia (1) · Sweden (1) · United Kingdom (1) · United States (1)
Seyed Sina Naghibi Irvani, MD, MPH, MBA (4) · Ilad Alavi Darazam, MD (2) · Jan Tack (2) · Mehran Lack, MD (2) · Minoosh Shabani, MD (2) · Mohammad Fathi, MD (2) · Mohammadreza Haji Esmaelie, MD (2) · Nader Markazi, MD (2) · Nasser Malekpour Alamdari, MD (2) · Sanaz Zargar Balaye Jam, MD (2) · Sasan Tavana, MD (2) · Shervin Shokouhi, MD (2) · Denis Martinez (1) · Eugene Sobngwi (1)
PMID 10649166, PMID 21417950, PMID 22753402, PMID 23908187, PMID 25274892, PMID 25617818, PMID 26421409, PMID 26429521, PMID 28376912, PMID 30295425, PMID 31732558, PMID 32503662, PMID 33082342, PMID 34263700, PMID 34273635, PMID 34535165, PMID 34764044, PMID 37591523, PMID 38299639, PMID 40548492
2014 (1), 2016 (1)